ID
33691
Description
Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains information about any unscheduled blood sampling for pharmakokinetics. It should be filled out at follow up visit. It should be filled out at each visit, if any unscheduled blood samples for pharmacokinetics had been taken. Screening Visit: 28 days prior to first dosing. Treatment Period: The day before dosing, until 48h after dosing. Follow-Up: 14-21 days after last dose
Keywords
Versions (3)
- 12/3/18 12/3/18 -
- 12/19/18 12/19/18 -
- 1/9/19 1/9/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 19, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Effect of Lamictal on Resting Motor Threshold Study-ID 107434
Unscheduled Blood Sampling for PK
- StudyEvent: ODM
Similar models
Unscheduled Blood Sampling for PK
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C3854240 (UMLS CUI [1,2])
C1552089 (UMLS CUI [1,2])
C3854240 (UMLS CUI-2)
C0031327 (UMLS CUI-3)
C1299222 (UMLS CUI [1,2])
C0871685 (UMLS CUI [1,2])